+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Synthetic Biology Market by Tools (DNA Tools, General Tools, Mathematical Modelling & Computer-aided Design Tools), Technology (Bioinformatics, Cell Sequencing, Cell Synthesis & Assembly), End-Use - Forecast 2024-2030

  • PDF Icon

    Report

  • 186 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5533152
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Synthetic Biology Market size was estimated at USD 13.88 billion in 2023, USD 16.61 billion in 2024, and is expected to grow at a CAGR of 21.33% to reach USD 53.76 billion by 2030.

Synthetic biology focuses on applying engineering principles to develop new biological parts, devices, and systems or redesign existing systems found in nature. Synthetic biology incorporates many scientific techniques and approaches to create fully operational biological systems from the smallest constituent parts possible, including DNA, proteins, and other organic molecules. The prevalence of chronic diseases and the need for efficient diagnosis are accelerating the use of synthetic biology for novel drug and vaccine development and innovative point-of-care diagnostics devices. However, hazards and risks associated with synthetic biology technology may limit their use by the end-use industries. Moreover, advancements in gene editing, next-generation sequencing, ongoing research, and significant investments to increase the application of synthetic biology across various end-use sectors are expected to encourage the growth of the synthetic biology market.

Regional Insights
The synthetic biology market is highly evolving across the Americas owing to the growing adoption of synthetic biology in the medical and agricultural sectors, rising investments in genomics and proteomics, and the surging development of improved medical devices using synthetic biology technology. Increasing chronic disease cases and rising emphasis on drug discovery & development are expanding the usage of synthetic biology applications in the APAC region. Moreover, government initiatives and programs to accelerate the use and expand research activities in the synthetic biology field are creating significant potential for the growth of the synthetic biology market in the EMEA region. Additionally, ongoing collaborations and partnership activities, along with the integration of breakthrough technologies for developing cutting-edge devices and technologies to increase their use across various industrial verticals, are expected to encourage the growth of the synthetic biology market worldwide.

FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Synthetic Biology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Synthetic Biology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles
The report delves into recent significant developments in the Synthetic Biology Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Amyris, Inc., Arzeda, Batavia Biosciences B.V., Beam Therapeutics, Beckman Coulter, Inc., BGI Genomics Co., Ltd., Codexis, Inc., Conagen, Inc., Creative Enzymes, DNA TwoPointO Inc., Editas Medicine, Inc., Eurofins Scientific, GenScript Biotech Corporation, Ginkgo Bioworks, Inc., Illumina, Inc., Integrated DNA Technologies, Inc., Merck KGaA, New England Biolabs GmbH, Novozymes A/S, Precigen, Inc., QIAGEN N.V., Sangamo Therapeutics, Scarab Genomics, LLC, Synlogic, Synthego Corporation, TeselaGen Service, Thermo Fisher Scientific Inc., and Twist Bioscience Corporation.

Market Segmentation & Coverage
This research report categorizes the Synthetic Biology Market to forecast the revenues and analyze trends in each of the following sub-markets:

- Tools- DNA Tools
- General Tools
- Mathematical Modelling & Computer-aided Design Tools
- Protein Tools
- RNA Tools
- Technology- Bioinformatics
- Cell Sequencing
- Cell Synthesis & Assembly
- Cloning
- Microfluidics
- Nanotechnology
- Omics Technologies
- Site-directed Mutagenesis
- End-Use- Agriculture
- Cosmetics & Personal Care
- Energy & Natural Resources
- Environment- Bioremediation
- Biosensing
- Food & Beverage
- Healthcare & Pharmaceuticals- Artificial Tissue & Tissue Regeneration
- Drug Discovery & Therapeutics
- Paper & Textile
- Region- Americas- Argentina
- Brazil
- Canada
- Mexico
- United States- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
- What is the market size and forecast of the Synthetic Biology Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Synthetic Biology Market?
- What are the technology trends and regulatory frameworks in the Synthetic Biology Market?
- What is the market share of the leading vendors in the Synthetic Biology Market?
- Which modes and strategic moves are suitable for entering the Synthetic Biology Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Synthetic Biology Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing use for novel drug and vaccines development
5.1.1.2. Expansion of synthetic biology based point-of-care diagnostics devices
5.1.1.3. Accelerating demand for synthetic biology in various industrial applications
5.1.2. Restraints
5.1.2.1. Risks associated with the use of synthetic biology technology
5.1.3. Opportunities
5.1.3.1. Technological advancements in gene editing and next generation sequencing
5.1.3.2. Rising R&D funding and investments for expansion of synthetic biology applications
5.1.4. Challenges
5.1.4.1. Constraints of synthetic biology in modularization and standardization of biological parts
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Synthetic Biology Market, by Tools
6.1. Introduction
6.2. DNA Tools
6.3. General Tools
6.4. Mathematical Modelling & Computer-aided Design Tools
6.5. Protein Tools
6.6. RNA Tools
7. Synthetic Biology Market, by Technology
7.1. Introduction
7.2. Bioinformatics
7.3. Cell Sequencing
7.4. Cell Synthesis & Assembly
7.5. Cloning
7.6. Microfluidics
7.7. Nanotechnology
7.8. Omics Technologies
7.9. Site-directed Mutagenesis
8. Synthetic Biology Market, by End-Use
8.1. Introduction
8.2. Agriculture
8.3. Cosmetics & Personal Care
8.4. Energy & Natural Resources
8.5. Environment
8.6.1. Bioremediation
8.6.2. Biosensing
8.6. Food & Beverage
8.7. Healthcare & Pharmaceuticals
8.8.1. Artificial Tissue & Tissue Regeneration
8.8.2. Drug Discovery & Therapeutics
8.8. Paper & Textile
9. Americas Synthetic Biology Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Synthetic Biology Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Synthetic Biology Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Merger & Acquisition
12.3.1.1. Moderna, Becoming A Buyer, Acquires A Synthetic Biology Specialist.
12.3.1.2. Ginkgo To Acquire Synbio Competitor Zymergen.
12.3.2. Agreement, Collaboration, & Partnership
12.3.2.1. Asimov Partners With IGEM To Support The Next Generation of Synthetic Biologists.
12.3.3. New Product Launch & Enhancement
12.3.3.1. NREL Launches Synthetic Biology Project To Advance Biofuel Discovery Technologies With LanzaTech, Northwestern, and Yale.
12.3.3.2. Tierra Biosciences Launches ‘proteins-On-Demand’ Platform To Speed Up Synbio Engineering.
12.3.4. Investment & Funding
12.3.4.1. Synthetic Biology Startup D-Nome Raises USD 1.5 Million In Funding From Ankur Capital, Campus Fund.
12.3.4.2. Northwestern and MIT Receive Funding From Army’s Synthetic Biology Center.
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Agilent Technologies, Inc.
13.1.2. Amyris, Inc.
13.1.3. Arzeda
13.1.4. Batavia Biosciences B.V.
13.1.5. Beam Therapeutics
13.1.6. Beckman Coulter, Inc.
13.1.7. BGI Genomics Co., Ltd.
13.1.8. Codexis, Inc.
13.1.9. Conagen, Inc.
13.1.10. Creative Enzymes
13.1.11. DNA TwoPointO Inc.
13.1.12. Editas Medicine, Inc.
13.1.13. Eurofins Scientific
13.1.14. GenScript Biotech Corporation
13.1.15. Ginkgo Bioworks, Inc.
13.1.16. Illumina, Inc.
13.1.17. Integrated DNA Technologies, Inc.
13.1.18. Merck KGaA
13.1.19. New England Biolabs GmbH
13.1.20. Novozymes A/S
13.1.21. Precigen, Inc.
13.1.22. QIAGEN N.V.
13.1.23. Sangamo Therapeutics
13.1.24. Scarab Genomics, LLC
13.1.25. Synlogic
13.1.26. Synthego Corporation
13.1.27. TeselaGen Service
13.1.28. Thermo Fisher Scientific Inc.
13.1.29. Twist Bioscience Corporation
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. SYNTHETIC BIOLOGY MARKET RESEARCH PROCESS
FIGURE 2. SYNTHETIC BIOLOGY MARKET SIZE, 2023 VS 2030
FIGURE 3. SYNTHETIC BIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. SYNTHETIC BIOLOGY MARKET DYNAMICS
FIGURE 7. SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2023 VS 2030 (%)
FIGURE 8. SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 12. SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. SYNTHETIC BIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. SYNTHETIC BIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. SYNTHETIC BIOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. SYNTHETIC BIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SYNTHETIC BIOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 6. SYNTHETIC BIOLOGY MARKET SIZE, BY DNA TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. SYNTHETIC BIOLOGY MARKET SIZE, BY GENERAL TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. SYNTHETIC BIOLOGY MARKET SIZE, BY MATHEMATICAL MODELLING & COMPUTER-AIDED DESIGN TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. SYNTHETIC BIOLOGY MARKET SIZE, BY PROTEIN TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. SYNTHETIC BIOLOGY MARKET SIZE, BY RNA TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 12. SYNTHETIC BIOLOGY MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. SYNTHETIC BIOLOGY MARKET SIZE, BY CELL SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. SYNTHETIC BIOLOGY MARKET SIZE, BY CELL SYNTHESIS & ASSEMBLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. SYNTHETIC BIOLOGY MARKET SIZE, BY CLONING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. SYNTHETIC BIOLOGY MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. SYNTHETIC BIOLOGY MARKET SIZE, BY NANOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. SYNTHETIC BIOLOGY MARKET SIZE, BY OMICS TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. SYNTHETIC BIOLOGY MARKET SIZE, BY SITE-DIRECTED MUTAGENESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 21. SYNTHETIC BIOLOGY MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. SYNTHETIC BIOLOGY MARKET SIZE, BY COSMETICS & PERSONAL CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. SYNTHETIC BIOLOGY MARKET SIZE, BY ENERGY & NATURAL RESOURCES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 26. SYNTHETIC BIOLOGY MARKET SIZE, BY BIOREMEDIATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. SYNTHETIC BIOLOGY MARKET SIZE, BY BIOSENSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. SYNTHETIC BIOLOGY MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 31. SYNTHETIC BIOLOGY MARKET SIZE, BY ARTIFICIAL TISSUE & TISSUE REGENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. SYNTHETIC BIOLOGY MARKET SIZE, BY DRUG DISCOVERY & THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. SYNTHETIC BIOLOGY MARKET SIZE, BY PAPER & TEXTILE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 50. CANADA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 51. CANADA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 52. CANADA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 53. CANADA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 54. CANADA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 55. MEXICO SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 56. MEXICO SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 57. MEXICO SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 58. MEXICO SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 59. MEXICO SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 72. AUSTRALIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 77. CHINA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 78. CHINA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. CHINA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 80. CHINA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 81. CHINA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 82. INDIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 83. INDIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. INDIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 85. INDIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 86. INDIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 87. INDONESIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 88. INDONESIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 89. INDONESIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 90. INDONESIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 91. INDONESIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 92. JAPAN SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 93. JAPAN SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. JAPAN SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 95. JAPAN SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 96. JAPAN SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 97. MALAYSIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 98. MALAYSIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. MALAYSIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 100. MALAYSIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 101. MALAYSIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 102. PHILIPPINES SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 103. PHILIPPINES SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 104. PHILIPPINES SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 105. PHILIPPINES SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 106. PHILIPPINES SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 107. SINGAPORE SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 108. SINGAPORE SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 109. SINGAPORE SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 110. SINGAPORE SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 111. SINGAPORE SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 112. SOUTH KOREA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 113. SOUTH KOREA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. SOUTH KOREA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 115. SOUTH KOREA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 116. SOUTH KOREA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 117. TAIWAN SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 118. TAIWAN SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. TAIWAN SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 120. TAIWAN SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 121. TAIWAN SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 122. THAILAND SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 123. THAILAND SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. THAILAND SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 125. THAILAND SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 126. THAILAND SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 127. VIETNAM SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 128. VIETNAM SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. VIETNAM SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 130. VIETNAM SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 131. VIETNAM SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 138. DENMARK SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 139. DENMARK SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. DENMARK SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 141. DENMARK SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 142. DENMARK SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 143. EGYPT SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 144. EGYPT SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. EGYPT SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 146. EGYPT SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 147. EGYPT SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 148. FINLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 149. FINLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 150. FINLAND SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 151. FINLAND SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 152. FINLAND SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 153. FRANCE SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 154. FRANCE SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. FRANCE SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 156. FRANCE SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 157. FRANCE SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 158. GERMANY SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 159. GERMANY SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. GERMANY SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 161. GERMANY SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 162. GERMANY SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 163. ISRAEL SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 164. ISRAEL SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. ISRAEL SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 166. ISRAEL SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 167. ISRAEL SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 168. ITALY SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 169. ITALY SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 170. ITALY SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 171. ITALY SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 172. ITALY SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 174. NETHERLANDS SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 178. NIGERIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 179. NIGERIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 180. NIGERIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 181. NIGERIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 182. NIGERIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 183. NORWAY SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 184. NORWAY SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. NORWAY SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 186. NORWAY SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 187. NORWAY SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 188. POLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 189. POLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 190. POLAND SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 191. POLAND SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 192. POLAND SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 193. QATAR SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 194. QATAR SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. QATAR SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 196. QATAR SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 197. QATAR SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 202. RUSSIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 204. SAUDI ARABIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 210. SOUTH AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 212. SOUTH AFRICA SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 213. SPAIN SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 214. SPAIN SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. SPAIN SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 216. SPAIN SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 217. SPAIN SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 218. SWEDEN SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 219. SWEDEN SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 220. SWEDEN SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 221. SWEDEN SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 222. SWEDEN SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 223. SWITZERLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 224. SWITZERLAND SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 225. SWITZERLAND SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 226. SWITZERLAND SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 227. SWITZERLAND SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 228. TURKEY SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 229. TURKEY SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 230. TURKEY SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 231. TURKEY SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 232. TURKEY SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM SYNTHETIC BIOLOGY MARKET SIZE, BY TOOLS, 2018-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 240. UNITED KINGDOM SYNTHETIC BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENT, 2018-2030 (USD MILLION)
TABLE 242. UNITED KINGDOM SYNTHETIC BIOLOGY MARKET SIZE, BY HEALTHCARE & PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 243. SYNTHETIC BIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 244. SYNTHETIC BIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 245. SYNTHETIC BIOLOGY MARKET LICENSE & PRICING

Companies Mentioned

  • Agilent Technologies, Inc.
  • Amyris, Inc.
  • Arzeda
  • Batavia Biosciences B.V.
  • Beam Therapeutics
  • Beckman Coulter, Inc.
  • BGI Genomics Co., Ltd.
  • Codexis, Inc.
  • Conagen, Inc.
  • Creative Enzymes
  • DNA TwoPointO Inc.
  • Editas Medicine, Inc.
  • Eurofins Scientific
  • GenScript Biotech Corporation
  • Ginkgo Bioworks, Inc.
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc.
  • Merck KGaA
  • New England Biolabs GmbH
  • Novozymes A/S
  • Precigen, Inc.
  • QIAGEN N.V.
  • Sangamo Therapeutics
  • Scarab Genomics, LLC
  • Synlogic
  • Synthego Corporation
  • TeselaGen Service
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation

Methodology

Loading
LOADING...

Table Information